184 related articles for article (PubMed ID: 28515148)
1. NEMO, a Transcriptional Target of Estrogen and Progesterone, Is Linked to Tumor Suppressor PML in Breast Cancer.
Elsarraj HS; Valdez KE; Hong Y; Grimm SL; Ricci LR; Fan F; Tawfik O; May L; Cusick T; Inciardi M; Redick M; Gatewood J; Winblad O; Hilsenbeck S; Edwards DP; Hagan CR; Godwin AK; Fabian C; Behbod F
Cancer Res; 2017 Jul; 77(14):3802-3813. PubMed ID: 28515148
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 6 signaling regulates promyelocytic leukemia protein gene expression in human normal and cancer cells.
Hubackova S; Krejcikova K; Bartek J; Hodny Z
J Biol Chem; 2012 Aug; 287(32):26702-14. PubMed ID: 22711534
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor alpha transcriptionally activates casein kinase 2 alpha: A pivotal regulator of promyelocytic leukaemia protein (PML) and AKT in oncogenesis.
Das N; Datta N; Chatterjee U; Ghosh MK
Cell Signal; 2016 Jun; 28(6):675-87. PubMed ID: 27012497
[TBL] [Abstract][Full Text] [Related]
4. PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2.
Kuo HY; Huang YS; Tseng CH; Chen YC; Chang YW; Shih HM; Wu CW
Cell Cycle; 2014; 13(19):3132-42. PubMed ID: 25486572
[TBL] [Abstract][Full Text] [Related]
5. Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.
Kabos P; Finlay-Schultz J; Li C; Kline E; Finlayson C; Wisell J; Manuel CA; Edgerton SM; Harrell JC; Elias A; Sartorius CA
Breast Cancer Res Treat; 2012 Sep; 135(2):415-32. PubMed ID: 22821401
[TBL] [Abstract][Full Text] [Related]
6. miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.
Lee YM; Lee JY; Ho CC; Hong QS; Yu SL; Tzeng CR; Yang PC; Chen HW
Breast Cancer Res; 2011; 13(6):R116. PubMed ID: 22113133
[TBL] [Abstract][Full Text] [Related]
7. IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis.
Siersbæk R; Scabia V; Nagarajan S; Chernukhin I; Papachristou EK; Broome R; Johnston SJ; Joosten SEP; Green AR; Kumar S; Jones J; Omarjee S; Alvarez-Fernandez R; Glont S; Aitken SJ; Kishore K; Cheeseman D; Rakha EA; D'Santos C; Zwart W; Russell A; Brisken C; Carroll JS
Cancer Cell; 2020 Sep; 38(3):412-423.e9. PubMed ID: 32679107
[TBL] [Abstract][Full Text] [Related]
8. Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.
Elsarraj HS; Hong Y; Valdez KE; Michaels W; Hook M; Smith WP; Chien J; Herschkowitz JI; Troester MA; Beck M; Inciardi M; Gatewood J; May L; Cusick T; McGinness M; Ricci L; Fan F; Tawfik O; Marks JR; Knapp JR; Yeh HW; Thomas P; Carrasco DR; Fields TA; Godwin AK; Behbod F
Breast Cancer Res; 2015 Sep; 17():128. PubMed ID: 26384318
[TBL] [Abstract][Full Text] [Related]
9. PML promotes metastasis of triple-negative breast cancer through transcriptional regulation of HIF1A target genes.
Ponente M; Campanini L; Cuttano R; Piunti A; Delledonne GA; Coltella N; Valsecchi R; Villa A; Cavallaro U; Pattini L; Doglioni C; Bernardi R
JCI Insight; 2017 Feb; 2(4):e87380. PubMed ID: 28239645
[TBL] [Abstract][Full Text] [Related]
10. ATM- and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress.
Wu ZH; Wong ET; Shi Y; Niu J; Chen Z; Miyamoto S; Tergaonkar V
Mol Cell; 2010 Oct; 40(1):75-86. PubMed ID: 20932476
[TBL] [Abstract][Full Text] [Related]
11. Progesterone decreases levels of the adhesion protein E-cadherin and promotes invasiveness of steroid receptor positive breast cancers.
Kariagina A; Xie J; Langohr IM; Opreanu RC; Basson MD; Haslam SZ
Horm Cancer; 2013 Dec; 4(6):371-80. PubMed ID: 23996076
[TBL] [Abstract][Full Text] [Related]
12. Stratification and therapeutic potential of PML in metastatic breast cancer.
Martín-Martín N; Piva M; Urosevic J; Aldaz P; Sutherland JD; Fernández-Ruiz S; Arreal L; Torrano V; Cortazar AR; Planet E; Guiu M; Radosevic-Robin N; Garcia S; Macías I; Salvador F; Domenici G; Rueda OM; Zabala-Letona A; Arruabarrena-Aristorena A; Zúñiga-García P; Caro-Maldonado A; Valcárcel-Jiménez L; Sánchez-Mosquera P; Varela-Rey M; Martínez-Chantar ML; Anguita J; Ibrahim YH; Scaltriti M; Lawrie CH; Aransay AM; Iovanna JL; Baselga J; Caldas C; Barrio R; Serra V; Vivanco Md; Matheu A; Gomis RR; Carracedo A
Nat Commun; 2016 Aug; 7():12595. PubMed ID: 27553708
[TBL] [Abstract][Full Text] [Related]
13. Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.
Hao L; Rizzo P; Osipo C; Pannuti A; Wyatt D; Cheung LW; Sonenshein G; Osborne BA; Miele L
Oncogene; 2010 Jan; 29(2):201-13. PubMed ID: 19838210
[TBL] [Abstract][Full Text] [Related]
14. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
15. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.
Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
[TBL] [Abstract][Full Text] [Related]
16. Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells.
Sengupta S; Schiff R; Katzenellenbogen BS
Breast Cancer Res Treat; 2009 Sep; 117(2):243-51. PubMed ID: 18807177
[TBL] [Abstract][Full Text] [Related]
17. Inorganic arsenic promotes luminal to basal transition and metastasis of breast cancer.
Danes JM; de Abreu ALP; Kerketta R; Huang Y; Palma FR; Gantner BN; Mathison AJ; Urrutia RA; Bonini MG
FASEB J; 2020 Dec; 34(12):16034-16048. PubMed ID: 33047385
[TBL] [Abstract][Full Text] [Related]
18. Self-renewal of CD133(hi) cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer.
Sansone P; Ceccarelli C; Berishaj M; Chang Q; Rajasekhar VK; Perna F; Bowman RL; Vidone M; Daly L; Nnoli J; Santini D; Taffurelli M; Shih NN; Feldman M; Mao JJ; Colameco C; Chen J; DeMichele A; Fabbri N; Healey JH; Cricca M; Gasparre G; Lyden D; Bonafé M; Bromberg J
Nat Commun; 2016 Feb; 7():10442. PubMed ID: 26858125
[TBL] [Abstract][Full Text] [Related]
19. Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.
Shackleford TJ; Zhang Q; Tian L; Vu TT; Korapati AL; Baumgartner AM; Le XF; Liao WS; Claret FX
Breast Cancer Res; 2011 Jun; 13(3):R65. PubMed ID: 21689417
[TBL] [Abstract][Full Text] [Related]
20. Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase III.
Finlay-Schultz J; Gillen AE; Brechbuhl HM; Ivie JJ; Matthews SB; Jacobsen BM; Bentley DL; Kabos P; Sartorius CA
Cancer Res; 2017 Sep; 77(18):4934-4946. PubMed ID: 28729413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
